Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology

Department of Medicine (Cardiology), St. Elizabeth's Hospital, Tufts University School of Medicine, Boston, Massachusetts 02135.

OBJECTIVES. The purpose of this study was to determine whether the kinetics of smooth muscle cell outgrowth from in vitro explants of human atherosclerotic tissue is dependent on the nature of the atherosclerotic lesion in vivo. BACKGROUND. The use of techniques for percutaneous in vivo extraction of atherosclerotic plaque has provided the opportunity to study human atheroma-derived smooth muscle cells in culture. However, because of cell selection and changes in phenotype, in vitro findings may not always reflect the biologic properties of the vessel wall, particularly if cells are in culture for prolonged periods. In contrast, studies with nonhuman cells have suggested that the rate at which cells grow out of tissue explants is closely related to the status of the cells in vivo. METHODS. Atherosclerotic tissue from 41 lesions, including primary plaques (from peripheral arteries and venous bypass conduits) and restenotic lesions (from peripheral arteries and venous conduits) were divided into a total of 1,596 fragments and placed in culture on fibronectin-coated wells. Explant outgrowth was scored over the ensuing 1 month to determine the prevalence and time course of smooth muscle cell outgrowth and the total cellular accumulation. RESULTS. Explant fragments from 40 (98%) of the 41 lesions yielded an outgrowth of smooth muscle cells, confirmed by immunocytochemistry. The mean proportion of adherent explant fragments yielding outgrowth, per lesion, was 69 +/- 4% and was higher in restenotic tissue (81 +/- 3%) than in primary tissue (56 +/- 6%, p < 0.001). For primary lesions, initiation of outgrowth was half-maximal by 8.7 +/- 0.4 days; for restenotic explants, initiation of outgrowth was considerably faster (half-maximal by 5.9 +/- 0.6 days, p < 0.001). Similarly, accumulation of smooth muscle cells around an explant was significantly greater for restenotic lesions (2,791 +/- 631 cells/explant) than for primary lesions (653 +/- 144 cells/explant, p < 0.01). Labeling of first-passage cells with [3H]-thymidine indicated that cells from restenotic lesions had a 1.3-fold greater incorporation rate than did cells from primary lesions (p < 0.05). CONCLUSIONS. Smooth muscle cells may be reliably cultivated by explant outgrowth from a variety of human atherosclerotic plaque types obtained intraoperatively or percutaneously. The kinetics of outgrowth from restenotic tissue is distinctly different from that of outgrowth from primary tissue, suggesting a relation between the in vitro outgrowth behavior and the biology of the lesion in vivo. Assessment of smooth muscle cell outgrowth from human atherosclerotic plaque may thus represent a practical and reliable means to investigate the biologic behavior, including growth characteristics, of individual atherosclerotic lesions from human subjects. This technique may also offer a suitable assay system for evaluating therapies designed to inhibit lesion proliferation.

This article has been cited by other articles:

				A. Rivard, N. Principe, and V. Andres Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells: A potential link between aging, smooth muscle cell proliferation and atherosclerosis Cardiovasc Res, March 1, 2000; 45(4): 1026 - 1034. [Abstract] [Full Text] [PDF]

				D. B. Schneider, G. Vassalli, S. Wen, R. M. Driscoll, A. B. Sassani, M. B. DeYoung, R. Linnemann, R. Virmani, and D. A. Dichek Expression of Fas Ligand in Arteries of Hypercholesterolemic Rabbits Accelerates Atherosclerotic Lesion Formation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 298 - 308. [Abstract] [Full Text] [PDF]

				M. Sata, T. Suhara, and K. Walsh Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand-Induced Cell Death : Implications for Vascular Disease and Therapy Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 309 - 316. [Abstract] [Full Text] [PDF]

				A.-C. Desfaits, J. Raymond, and J. P. Muizelaar Growth Factors Stimulate Neointimal Cells In Vitro and Increase the Thickness of the Neointima Formed at the Neck of Porcine Aneurysms Treated by Embolization • Editorial Comment Stroke, February 1, 2000; 31(2): 498 - 507. [Abstract] [Full Text] [PDF]

				J. G. Pickering, L. H. Chow, S. Li, K. A. Rogers, E. F. Rocnik, R. Zhong, and B. M. C. Chan {alpha}5{beta}1 Integrin Expression and Luminal Edge Fibronectin Matrix Assembly by Smooth Muscle Cells after Arterial Injury Am. J. Pathol., February 1, 2000; 156(2): 453 - 465. [Abstract] [Full Text] [PDF]

				H. Ishibashi-Ueda, C. Yutani, M. Imakita, S. Kuribayashi, M. Takamiya, H. Uchida, K. Kichikawa, T. Suzuki, and H. Ishibashi-Ueda Histologic Comparison of Coronary and Iliac Atherectomy Tissue from Cases of In-Stent Restenosis Angiology, December 1, 1999; 50(12): 977 - 987. [Abstract] [PDF]

				D. Chen, K. Guo, J. Yang, W. A. Frazier, J. M. Isner, and V. Andres Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21Cip1/WAF1 Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1100 - H1106. [Abstract] [Full Text] [PDF]

				D. Chen, T. Asahara, K. Krasinski, B. Witzenbichler, J. Yang, M. Magner, M. Kearney, W. A. Frazier, J. M. Isner, and V. Andres Antibody Blockade of Thrombospondin Accelerates Reendothelialization and Reduces Neointima Formation in Balloon-Injured Rat Carotid Artery Circulation, August 24, 1999; 100(8): 849 - 854. [Abstract] [Full Text] [PDF]

				S. Li, S. Sims, Y. Jiao, L. H. Chow, and J. G. Pickering Evidence From a Novel Human Cell Clone That Adult Vascular Smooth Muscle Cells Can Convert Reversibly Between Noncontractile and Contractile Phenotypes Circ. Res., August 20, 1999; 85(4): 338 - 348. [Abstract] [Full Text] [PDF]

				C. M. Ford, S. Li, and J. G. Pickering Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells : Involvement of the AT1 Receptor, Transforming Growth Factor-{beta}, and Tyrosine Phosphorylation Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1843 - 1851. [Abstract] [Full Text] [PDF]

				A. J. Lansky, G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, D. S. Baim, R. E. Kuntz, C. Simonton, R. M. Bersin, et al. Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the optimal atherectomy restenosis study J. Am. Coll. Cardiol., August 1, 1998; 32(2): 329 - 337. [Abstract] [Full Text] [PDF]

				B. Witzenbichler, P. C. Maisonpierre, P. Jones, G. D. Yancopoulos, and J. M. Isner Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2 J. Biol. Chem., July 17, 1998; 273(29): 18514 - 18521. [Abstract] [Full Text] [PDF]

				G. Bauriedel, S. Schluckebier, R. Hutter, U. Welsch, R. Kandolf, B. Luderitz, and M. F. Prescott Apoptosis in Restenosis Versus Stable-Angina Atherosclerosis : Implications for the Pathogenesis of Restenosis Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1132 - 1139. [Abstract] [Full Text] [PDF]

				E. Van Belle, B. Witzenbichler, D. Chen, M. Silver, L. Chang, R. Schwall, and J. M. Isner Potentiated Angiogenic Effect of Scatter Factor/Hepatocyte Growth Factor via Induction of Vascular Endothelial Growth Factor : The Case for Paracrine Amplification of Angiogenesis Circulation, February 3, 1998; 97(4): 381 - 390. [Abstract] [Full Text] [PDF]

				R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text]

				R. C. Smith, K. N. Wills, D. Antelman, H. Perlman, L. N. Truong, K. Krasinski, and K. Walsh Adenoviral Constructs Encoding Phosphorylation-Competent Full-length and Truncated Forms of the Human Retinoblastoma Protein Inhibit Myocyte Proliferation and Neointima Formation Circulation, September 16, 1997; 96(6): 1899 - 1905. [Abstract] [Full Text]

				L. Maillard, E. Van Belle, R. C Smith, A. Le Roux, P. Denefle, G. Steg, J. J Barry, D. Branellec, J. M Isner, and K. Walsh Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty Cardiovasc Res, September 1, 1997; 35(3): 536 - 546. [Abstract] [Full Text] [PDF]

				R C Smith, D Branellec, D H Gorski, K Guo, H Perlman, J F Dedieu, C Pastore, A Mahfoudi, P Denefle, J M Isner, et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes & Dev., July 1, 1997; 11(13): 1674 - 1689. [Abstract] [PDF]

				J. G. Pickering, S. Uniyal, C. M. Ford, T. Chau, M. A. Laurin, L. H. Chow, C. G. Ellis, J. Fish, and B. M. C. Chan Fibroblast Growth Factor-2 Potentiates Vascular Smooth Muscle Cell Migration to Platelet-Derived Growth Factor : Upregulation of {alpha}2ß1 Integrin and Disassembly of Actin Filaments Circ. Res., May 19, 1997; 80(5): 627 - 637. [Abstract] [Full Text]

				J. G. Pickering, C. M. Ford, B. Tang, and L. H. Chow Coordinated Effects of Fibroblast Growth Factor-2 on Expression of Fibrillar Collagens, Matrix Metalloproteinases, and Tissue Inhibitors of Matrix Metalloproteinases by Human Vascular Smooth Muscle Cells : Evidence for Repressed Collagen Production and Activated Degradative Capacity Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 475 - 482. [Abstract] [Full Text]

				G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, S. Chiu Wong, M. K. Hong, J. A. Kovach, and M. B. Leon Arterial Remodeling After Coronary Angioplasty : A Serial Intravascular Ultrasound Study Circulation, July 1, 1996; 94(1): 35 - 43. [Abstract] [Full Text]

				J. G. Pickering, J. M. Isner, C. M. Ford, L. Weir, A. Lazarovits, E. F. Rocnik, and L. H. Chow Processing of Chimeric Antisense Oligonucleotides by Human Vascular Smooth Muscle Cells and Human Atherosclerotic Plaque : Implications for Antisense Therapy of Restenosis After Angioplasty Circulation, February 15, 1996; 93(4): 772 - 780. [Abstract] [Full Text]

				S. Li, L. H. Chow, and J. G. Pickering Cell Surface-bound Collagenase-1 and Focal Substrate Degradation Stimulate the Rear Release of Motile Vascular Smooth Muscle Cells J. Biol. Chem., November 3, 2000; 275(45): 35384 - 35392. [Abstract] [Full Text] [PDF]

				S. Li, Y.-S. Fan, L. H. Chow, C. Van Den Diepstraten, E. van der Veer, S. M. Sims, and J. G. Pickering Innate Diversity of Adult Human Arterial Smooth Muscle Cells: Cloning of Distinct Subtypes From the Internal Thoracic Artery Circ. Res., September 14, 2001; 89(6): 517 - 525. [Abstract] [Full Text] [PDF]